CNS and Neurological Disorders - Drug Targets

SJR Rank #7,051H-index: 105SJR: 0.789Best quartile: Q2
Publisher

Bentham Science Publishers

Country

United Arab Emirates

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Medicine (miscellaneous)Q2
  • Neuroscience (miscellaneous)Q2
  • PharmacologyQ2

Areas: Medicine · Neuroscience · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Alzheimer's disease research and treatmentsTryptophan and brain disordersCholinesterase and Neurodegenerative DiseasesNeuroscience and Neuropharmacology ResearchNeuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and TreatmentsNeurological Disorders and TreatmentsDiverse Scientific and Economic StudiesNeurological Disease Mechanisms and Treatments14-3-3 protein interactions

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs085170255340

Documents per Year

202220250306090120

Detailed Information

ISSN

1871-5273, 1996-3181

SJR Best Quartile

Q2

Region

Middle East

Citations per Document (2 years)

3.67

References per Document

104.60

Coverage

2006-2026

Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Metrics from SCImago Journal Rank 2025. View on SCImago